| TGA Action ID |
RC-2025-RN-00926-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
Xpert CT/NG. An in vitro diagnostic medical device (IVD)
Product Code: GXCT/NGX-CE-10
All batch and lot numbers |
| ARTG Number |
207540 |
| Unique Device Identifier (UDI) |
N/A |
| Action Type |
Product Alert |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
Cepheid has become aware of a rare genetic mutation event between Neisseria gonorrhoeae and Neisseria meningitidis that caused some Neisseria gonorrhoeae strains to lack target sites for the Cepheid Xpert CT/NG test, leading to false negative results.
A false negative test result for Neisseria gonorrhoeae (NG) may occur. This could lead to transmission of disease and/or disease progression.
This limitation is noted in the product Instructions for Use (301-0234, Sec 18) “Mutations or other changes within the regions of the bacterial genomes covered by the primers and/or probes in the Xpert test may result in failure to detect the target organisms.” |
| Instructions for Customers/Users |
Customers are to: - Monitor for decreases in positivity rate when using the Xpert CT/NG test as the molecular method for detection of N. gonorrhoeae. - Investigate conflicting laboratory results further and report them to Cepheid.
This action has been closed out on 04/02/2026 |
| Action Commencement Date |
31/10/2025 |
| Responsible Entity |
|
| Contact Information |
1800 130 821 - Cepheid Holdings |